Trevi Therapeutics reported net income of -$18.03M for the quarter ended Jun 2026. This income statement covers 34 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 18.55M | 22.84M | 30.81M | 59.54M | 58.32M | 59.94M | 98.61M | 98.70M | 99.33M | 99.03M | 99.52M | 101.04M | 101.28M | 93.60M | 99.89M | 121.78M | 128.22M | 128.31M | 128.41M | 142.42M | ||||||||||||||
| Operating items | ||||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 4.72M | 6.18M | 4.64M | 5.10M | 5.77M | 4.32M | ||||||||||||||||||||||||||||
| Selling, General & AdministrativeSG&A | 2.23M | 2.09M | 2.38M | 2.72M | 2.64M | 2.34M | ||||||||||||||||||||||||||||
| Operating ExpensesOpex | 6.95M | 8.27M | 7.03M | 7.82M | 8.40M | 6.66M | ||||||||||||||||||||||||||||
| Operating IncomeOp. Inc | -6.95M | -8.27M | -7.03M | -7.82M | -8.40M | -6.66M | ||||||||||||||||||||||||||||
| EBIT | -6.95M | -8.27M | -7.03M | -7.82M | -8.40M | -6.66M | -6.41M | -7.17M | -7.71M | -7.80M | -10.91M | -12.36M | -13.27M | -11.40M | -10.35M | -12.32M | -11.82M | -8.33M | -13.21M | -17.82M | ||||||||||||||
| Non-operating items | ||||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.30M | 0.31M | 0.30M | 0.29M | 0.29M | 0.27M | ||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.00M | 0.00M | 0.00M | 0.20M | 0.42M | 1.12M | ||||||||||||||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | -0.01M | -0.40M | -0.01M | -0.14M | 5.55M | |||||||||||||||||||||||||||||
| Non Operating IncomeNon Op. Inc. | -0.31M | -0.25M | -0.31M | -0.24M | 0.13M | 1.13M | ||||||||||||||||||||||||||||
| Net income details | ||||||||||||||||||||||||||||||||||
| EBT | -7.25M | -8.53M | -7.33M | -8.06M | -8.27M | -5.53M | -6.41M | -7.17M | -7.71M | -7.80M | -10.91M | -12.36M | -13.27M | -11.40M | -10.35M | -12.32M | -11.82M | -8.33M | -13.21M | -17.82M | ||||||||||||||
| Tax ProvisionsTaxes | 0.00M | -0.01M | -0.01M | -0.00M | -0.01M | -0.02M | -0.01M | -0.03M | -0.01M | 0.02M | -0.01M | -0.01M | -0.03M | -10.02M | -0.01M | -0.02M | -0.01M | -8.95M | -0.02M | -0.02M | ||||||||||||||
| Profit After TaxPAT | -7.25M | -8.52M | -7.33M | -8.19M | -8.39M | -5.29M | -6.40M | -7.30M | -7.70M | -7.76M | -10.94M | -12.37M | -13.24M | -11.41M | -10.34M | -12.35M | -11.80M | -8.33M | -13.53M | -18.03M | ||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -7.25M | -8.52M | -7.33M | -8.05M | -8.27M | -5.50M | -6.40M | -7.14M | -7.70M | -7.82M | -10.90M | -12.35M | -13.24M | -1.38M | -10.34M | -12.30M | -11.80M | 0.61M | -13.19M | -17.80M | ||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -7.25M | -8.52M | -7.33M | -8.05M | -8.27M | -5.50M | -6.40M | -7.14M | -7.70M | -7.82M | -10.90M | -12.35M | -13.24M | -1.38M | -10.34M | -12.30M | -11.80M | 0.61M | -13.19M | -17.80M | ||||||||||||||
| Income towards Parent CompanyParent Net Inc | -7.25M | -8.52M | -7.33M | -8.05M | -8.27M | -5.50M | -6.40M | -7.14M | -7.70M | -7.82M | -10.90M | -12.35M | -13.24M | -1.38M | -10.34M | -12.30M | -11.80M | 0.61M | -13.19M | -17.80M | ||||||||||||||
| Preferred Dividend PaymentsPref Dividends | ||||||||||||||||||||||||||||||||||
| Net Income towards Common StockholdersNet Income | -7.25M | -8.52M | -7.33M | -8.05M | -8.27M | -5.50M | -6.40M | -7.14M | -7.70M | -7.82M | -10.90M | -12.35M | -13.24M | -1.38M | -10.34M | -12.30M | -11.80M | 0.61M | -13.19M | -17.80M | ||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||
| EPS (Basic) | -0.34 | -0.37 | -0.24 | -0.14 | -0.12 | -0.09 | -0.06 | -0.07 | -0.08 | -0.08 | -0.11 | -0.12 | -0.13 | -0.01 | -0.09 | -0.09 | -0.08 | 0.00 | -0.09 | -0.11 | ||||||||||||||
| EPS (Diluted) | -0.34 | -0.37 | -0.24 | -0.14 | -0.12 | -0.09 | -0.06 | -0.07 | -0.08 | -0.08 | -0.11 | -0.12 | -0.13 | -0.01 | -0.09 | -0.09 | -0.08 | 0.00 | -0.09 | -0.11 | ||||||||||||||
| Shares Outstanding | 21.61M | 22.84M | 30.81M | 59.54M | 68.90M | 64.54M | 98.61M | 98.70M | 99.33M | 99.03M | 99.52M | 101.04M | 101.28M | 101.97M | 117.61M | 130.35M | 145.10M | 134.75M | 145.59M | 156.60M | ||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 21.61M | 22.84M | 30.81M | 59.54M | 68.90M | 64.54M | 98.61M | 98.70M | 99.33M | 99.03M | 99.52M | 101.04M | 101.28M | 101.97M | 117.61M | 130.35M | 145.10M | 134.75M | 145.59M | 156.60M | ||||||||||||||
| EBITDA | -6.95M | -8.27M | -7.03M | -7.82M | -8.40M | -6.66M | -6.41M | -7.17M | -7.71M | -7.80M | -10.91M | -12.36M | -13.27M | -11.40M | -10.35M | -12.32M | -11.82M | -8.33M | -13.21M | -17.82M | ||||||||||||||
| Interest ExpensesInt Expense | 0.30M | 0.31M | 0.30M | 0.29M | 0.29M | 0.27M | ||||||||||||||||||||||||||||
| Tax Rate | -0.03 | 0.07 | 0.07 | 0.05 | 0.08 | 0.36 | 0.11 | 0.42 | 0.17 | -0.23 | 0.07 | 0.06 | 0.23 | 87.92 | 0.11 | 0.17 | 0.13 | 107.36 | 0.15 | 0.11 |